xanthone has been researched along with tetradecanoylphorbol acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, P; Enjo, F; Furukawa, H; Ito, C; Itoigawa, M; Nishino, H; Rao, KS; Takayasu, J; Tokuda, H | 1 |
| Aye, A; Jeon, YD; Jin, JS; Song, YJ | 1 |
2 other study(ies) available for xanthone and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Xanthones as inhibitors of Epstein-Barr virus activation.
Topics: Antigens, Viral; Antineoplastic Agents; Carcinogens; Cell Survival; Dose-Response Relationship, Drug; Herpesvirus 4, Human; Humans; Plant Extracts; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Virus Activation; Xanthenes; Xanthones | 1998 |
Xanthone suppresses allergic contact dermatitis in vitro and in vivo.
Topics: Administration, Oral; Anaphylaxis; Animals; Anti-Allergic Agents; Calcimycin; Cell Line; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Inflammation Mediators; Keratinocytes; Male; Mast Cells; Mice; Mitogen-Activated Protein Kinases; p-Methoxy-N-methylphenethylamine; Phosphorylation; Skin; Tetradecanoylphorbol Acetate; Xanthones | 2020 |